NCT00986128View on ClinicalTrials.gov

A Pharmacokinetic Study of Lithium Before and During Topiramate Dosing in Bipolar Disorder Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 31, 2001

Study Completion Date

October 31, 2002

Conditions
Bipolar Disorder
Interventions
DRUG

topiramate

100 mg tablet twice daily for 3 weeks

DRUG

topiramate

One 100 mg and one 200 mg tablet twice daily for 3 weeks

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00986128 - A Pharmacokinetic Study of Lithium Before and During Topiramate Dosing in Bipolar Disorder Patients | Biotech Hunter | Biotech Hunter